The Deadly Duo: Diabetes and Cardiovascular Disease | Golden Age

Diabetes and cardiovascular disease are two of the most prevalent and devastating health conditions worldwide, with over 460 million people living with diabetes and 17.9 million deaths attributed to cardiovascular disease annually. The relationship between the two conditions is complex, with diabetes increasing the risk of cardiovascular disease by 2-4 times, and cardiovascular disease exacerbating diabetes complications. According to the World Health Organization (WHO), the global prevalence of diabetes has risen from 4.7% in 1980 to 8.5% in 2014, with a projected increase to 10.4% by 2030. The economic burden of these conditions is staggering, with estimated annual costs of $1.5 trillion for diabetes and $1.1 trillion for cardiovascular disease. Researchers like Dr. Bernard Zinman and Dr. Hertzel Gerstein have made significant contributions to our understanding of the link between diabetes and cardiovascular disease, with studies like the EMPA-REG OUTCOME trial and the CANVAS program shedding light on the benefits of SGLT2 inhibitors in reducing cardiovascular risk. As the global health community continues to grapple with these conditions, it is essential to address the social and economic determinants of health, such as access to healthcare, healthy food, and physical activity, to mitigate the impact of diabetes and cardiovascular disease.